We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
(-6.1%)
Cap. Flow
-$1.56B
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$352M |
| 2 |
Kroger
KR
|
+$279M |
| 3 |
AT&T
T
|
+$235M |
| 4 |
Intel
INTC
|
+$217M |
| 5 |
Edwards Lifesciences
EW
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$461M |
| 2 |
Merck
MRK
|
+$459M |
| 3 |
Coca-Cola
KO
|
+$295M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$283M |
| 5 |
TSMC
TSM
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.08% |
| 2 | Technology | 16.14% |
| 3 | Healthcare | 15.45% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Consumer Staples | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Moody's
MCO
$81.7B
| $39.9M | 0.09% |
164,173
+73,366
| +81% | +$21.3M |
|
252
CALL
Berkshire Hathaway Class B
BRK.B
$1.07T
| $39.8M | 0.09% |
149,200
+36,800
| +33% | +$10.5M |
|
253
Goldman Sachs
GS
$313B
| $39.8M | 0.09% |
135,727
-186,418
| -58% | -$60.4M |
|
254
Colgate-Palmolive
CL
$72.6B
| $39.6M | 0.09% |
563,076
+498,378
| +770% | +$39.1M |
|
255
PUT
SPDR Gold Trust
GLD
$131B
| $39.5M | 0.09% |
255,600
+99,600
| +64% | +$16M |
|
256
Kinder Morgan
KMI
$73.1B
| $39.3M | 0.09% |
2,359,853
+2,338,436
| +10,919% | +$41.6M |
|
|
SAGE
257
DELISTED
Sage Therapeutics
SAGE
| $39.3M | 0.09% |
1,002,660
-612,646
| -38% | -$23.7M |
|
258
Global E Online
GLBE
$6.08B
| $39.2M | 0.09% |
+1,463,499
| New | +$41.7M |
|
259
BioMarin Pharmaceuticals
BMRN
$11.5B
| $39.1M | 0.09% |
460,959
-127,659
| -22% | -$11.4M |
|
260
Workday
WDAY
$33.4B
| $38.8M | 0.09% |
254,875
-5,673
| -2% | -$888K |
|
261
Monolithic Power Systems
MPWR
$65.5B
| $38.5M | 0.08% |
105,928
-27,180
| -20% | -$12.1M |
|
|
WBA
262
DELISTED
Walgreens Boots Alliance
WBA
| $38.3M | 0.08% |
+1,219,299
| New | +$45.2M |
|
263
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
| $38.3M | 0.08% |
649,654
+466,294
| +254% | +$29.2M |
|
264
Micron Technology
MU
$1.04T
| $37.8M | 0.08% |
753,862
-348,390
| -32% | -$20.2M |
|
|
CHNG
265
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $37.7M | 0.08% |
1,372,838
+890,579
| +185% | +$22.1M |
|
266
Monster Beverage
MNST
$91.4B
| $37.6M | 0.08% |
865,838
+380,634
| +78% | +$17.5M |
|
267
Madison Square Garden
MSGS
$9.54B
| $37.5M | 0.08% |
274,733
+54
| +0% | +$8.38K |
|
|
APGB
268
DELISTED
Apollo Strategic Growth Capital II
APGB
| $37.5M | 0.08% |
3,797,333
| – | – |
|
269
ZIM Integrated Shipping Services
ZIM
$3B
| $37.4M | 0.08% |
1,592,960
+976,018
| +158% | +$40.3M |
|
270
Comstock Resources
CRK
$3.97B
| $37.4M | 0.08% |
2,165,009
+379,831
| +21% | +$6.29M |
|
271
Endava
DAVA
$141M
| $37.3M | 0.08% |
463,168
+134,619
| +41% | +$12.8M |
|
272
CALL
Johnson & Johnson
JNJ
$635B
| $37.3M | 0.08% |
228,600
+216,100
| +1,729% | +$36.6M |
|
273
CALL
iShares MSCI Emerging Markets ETF
EEM
$28B
| $37.3M | 0.08% |
1,069,300
+1,069,100
| +534,550% | +$41.7M |
|
274
PUT
Netflix
NFLX
$292B
| $37M | 0.08% |
1,570,000
-1,301,000
| -45% | -$28.9M |
|
275
Outfront Media
OUT
$5.64B
| $36.9M | 0.08% |
2,467,436
-48,385
| -2% | -$853K |
|
Similar funds
Marshall Wace's Q3 2022 Portfolio in Review
As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.
- Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
- Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
- Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
- Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
- Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
- Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
- Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.
Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.